NCT01069770 - Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2009

Primary Completion Date

December 31, 2011

Study Completion Date

June 30, 2012

Conditions

Clear Cell Renal Cell CarcinomaMetastasis

Interventions

DRUG

Sunitinib

50mg daily(4 weeks on \& 2 weeks off), 2 cycles, until progression or unacceptable toxicity develops

Trial Locations (3)

RECRUITING

National Cancer Center, Goyang-si

RECRUITING

Samsung Medical Center, Seoul

RECRUITING

Chungbuk University Hospital, Cheonju